De novo design of bioactive phenol and chromone derivatives for inhibitors of Spike glycoprotein of SARS-CoV-2 in silico

[1]  Rahul Singh,et al.  Multi‐target approach against SARS‐CoV‐2 by stone apple molecules: A master key to drug design , 2023, Phytotherapy research : PTR.

[2]  Rahul Singh,et al.  Computational analysis of protein-ligand interaction by targeting a cell cycle restrainer , 2023, Comput. Methods Programs Biomed..

[3]  Vijay Kumar Bhardwaj,et al.  Inhibition of nonstructural protein 15 of SARS‐CoV‐2 by golden spice: A computational insight , 2022, Cell biochemistry and function.

[4]  H. S. dos Santos,et al.  Predictive ADMET study of rhodanine-3-acetic acid chalcone derivatives , 2022, Journal of the Indian Chemical Society.

[5]  O. Mehrpour,et al.  Repurposing the drug, ivermectin, in COVID-19: toxicological points of view , 2022, European Journal of Medical Research.

[6]  Jike Wang,et al.  Deep learning approaches for de novo drug design: An overview. , 2021, Current opinion in structural biology.

[7]  Changsun Choi,et al.  Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction , 2021, Scientific Reports.

[8]  Zhiguo Yu,et al.  Identification of raloxifene as a novel α-glucosidase inhibitor using a systematic drug repurposing approach in combination with cross molecular docking-based virtual screening and experimental verification. , 2021, Carbohydrate research.

[9]  M. Ferreira,et al.  Diterpene Sonderianin isolated from Croton blanchetianus exhibits acetylcholinesterase inhibitory action and anxiolytic effect in adult zebrafish (Danio rerio) by 5-HT system , 2021, Journal of biomolecular structure & dynamics.

[10]  R. M. Ferreira,et al.  Outcomes associated with Hydroxychloroquine and Ivermectin in hospitalized patients with COVID-19: a single-center experience. , 2021, Revista da Associacao Medica Brasileira.

[11]  Amir Hossein Arshia,et al.  De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations , 2021, Computers in Biology and Medicine.

[12]  T. L. Sampaio,et al.  Molecular docking identification for the efficacy of natural limonoids against COVID-19 virus main protease , 2021, Journal of the Indian Chemical Society.

[13]  A. Oda,et al.  Molecular dynamics simulations for the protein–ligand complex structures obtained by computational docking studies using implicit or explicit solvents , 2021 .

[14]  R. Tumskiy,et al.  Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro , 2021, Chemical Physics Letters.

[15]  Liyan Yu,et al.  New phenol and chromone derivatives from the endolichenic fungus Daldinia species and their antiviral activities , 2021, RSC advances.

[16]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[17]  Syamal Roy,et al.  A review on potential of natural products in the management of COVID-19 , 2021, RSC advances.

[18]  Jianyang Zeng,et al.  An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 , 2021, Signal Transduction and Targeted Therapy.

[19]  M. Malim,et al.  SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity , 2021, SciAdv.

[20]  Haisun Zhu,et al.  Structural impact on SARS-CoV-2 spike protein by D614G substitution , 2021, Science.

[21]  M. Marinho,et al.  Virtual Screening of Citrus Flavonoid Tangeretin: A Promising Pharmacological Tool for the Treatment and Prevention of Zika fever and COVID-19 , 2021 .

[22]  Phạm Thị Hồng Minh,et al.  Screening Virtual ACE2 Enzyme Inhibitory Activity of Compounds for COVID-19 Treatment Based on Molecular Docking , 2020 .

[23]  Vinicius M. Alves,et al.  STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity , 2020, Environmental health perspectives.

[24]  Yongfei Cai,et al.  Structural impact on SARS-CoV-2 spike protein by D614G substitution , 2020, bioRxiv.

[25]  Tingyang Xu,et al.  MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm , 2020, Briefings Bioinform..

[26]  Stephan Immenschuh,et al.  Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections , 2020, Antioxidants.

[27]  Vimal K. Maurya,et al.  Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Coronavirus Disease 2019 (COVID-19).

[28]  Thomas Sander,et al.  Accuracy evaluation and addition of improved dihedral parameters for the MMFF94s , 2019, Journal of Cheminformatics.

[29]  Rui Miao,et al.  Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning , 2019, Scientific Reports.

[30]  Y. Ivanenkov,et al.  Are we Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity? , 2019, Journal of medicinal chemistry.

[31]  William Graf,et al.  Deep learning for cellular image analysis , 2019, Nature Methods.

[32]  O. Farago.  Langevin thermostat for robust configurational and kinetic sampling , 2019, Physica A: Statistical Mechanics and its Applications.

[33]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein–RNA complexes , 2018, RNA.

[34]  Daniel S. Kermany,et al.  Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.

[35]  G. Somero,et al.  Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs , 2018, Proceedings of the National Academy of Sciences.

[36]  Ray Luo,et al.  Recent Developments and Applications of the MMPBSA Method , 2018, Front. Mol. Biosci..

[37]  Mike Preuss,et al.  Planning chemical syntheses with deep neural networks and symbolic AI , 2017, Nature.

[38]  B. L. de Groot,et al.  CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.

[39]  N. Zefirov,et al.  Prediction of blood-brain barrier permeability of organic compounds , 2016, Doklady Biochemistry and Biophysics.

[40]  Tudor I. Oprea,et al.  BDDCS, the Rule of 5 and drugability. , 2016, Advanced drug delivery reviews.

[41]  A. Gurung,et al.  Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication. , 2016, Genetics and molecular research : GMR.

[42]  Anabella Villalobos,et al.  Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery. , 2016, ACS chemical neuroscience.

[43]  G. Chinea,et al.  A comparative molecular dynamics study of thermophilic and mesophilic β-fructosidase enzymes , 2015, Journal of Molecular Modeling.

[44]  S. Joshua Swamidass,et al.  Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network , 2015, ACS central science.

[45]  S. Genheden,et al.  The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities , 2015, Expert opinion on drug discovery.

[46]  Martha White,et al.  An Emphatic Approach to the Problem of Off-policy Temporal-Difference Learning , 2015, J. Mach. Learn. Res..

[47]  E. Benfenati,et al.  Comparison of in silico tools for evaluating rat oral acute toxicity† , 2015, SAR and QSAR in environmental research.

[48]  J. Baell,et al.  Chemistry: Chemical con artists foil drug discovery , 2014, Nature.

[49]  Alfonso Hernández,et al.  Insights into mechanism kinematics for protein motion simulation , 2014, BMC Bioinformatics.

[50]  Luciana Scotti,et al.  SAR, QSAR and docking of anticancer flavonoids and variants: a review. , 2013, Current topics in medicinal chemistry.

[51]  Wei Jiang,et al.  CHARMM-GUI Ligand Binder for Absolute Binding Free Energy Calculations and Its Application , 2013, J. Chem. Inf. Model..

[52]  Feixiong Cheng,et al.  In silico Prediction of Chemical Ames Mutagenicity , 2012, J. Chem. Inf. Model..

[53]  Marcus D. Hanwell,et al.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.

[54]  T. Govender,et al.  Molecular Modeling of T. rangeli, T. brucei gambiense, and T. evansi Sialidases in Complex with the DANA Inhibitor , 2012, Chemical biology & drug design.

[55]  W. Geldenhuys,et al.  The blood-brain barrier choline transporter. , 2012, Central nervous system agents in medicinal chemistry.

[56]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[57]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[58]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[59]  P. Verhoest,et al.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. , 2010, ACS chemical neuroscience.

[60]  P. Verhoest,et al.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. , 2010, ACS chemical neuroscience.

[61]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[62]  M. Edwards,et al.  Using the Golden Triangle to optimize clearance and oral absorption. , 2009, Bioorganic & medicinal chemistry letters.

[63]  Samuel Genheden,et al.  How to obtain statistically converged MM/GBSA results , 2009, J. Comput. Chem..

[64]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..

[65]  Peter Ertl,et al.  Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.

[66]  A. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[67]  Yong Wang,et al.  Site of metabolism prediction for six biotransformations mediated by cytochromes P450 , 2009, Bioinform..

[68]  G. Degliesposti,et al.  Binding Estimation after Refinement, a New Automated Procedure for the Refinement and Rescoring of Docked Ligands in Virtual Screening , 2009, Chemical biology & drug design.

[69]  K. Hevener,et al.  Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase , 2009, J. Chem. Inf. Model..

[70]  J. Hughes,et al.  Physiochemical drug properties associated with in vivo toxicological outcomes. , 2008, Bioorganic & medicinal chemistry letters.

[71]  M. Gleeson.  Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.

[72]  Katrin Stierand,et al.  Molecular complexes at a glance: automated generation of two-dimensional complex diagrams , 2006, Bioinform..

[73]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[74]  S. Jain,et al.  De novo drug design : An overview , 2004 .

[75]  Matthias Rarey,et al.  Automated Drawing of Structural Molecular Formulas under Constraints , 2004, J. Chem. Inf. Model..

[76]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[77]  D. Case,et al.  Modification of the Generalized Born Model Suitable for Macromolecules , 2000 .

[78]  B. Roe,et al.  How big is a drop? A volumetric assay of essential oils. , 1999, Journal of clinical nursing.

[79]  S. Petrova,et al.  The Origin of the Method of Steepest Descent , 1997 .

[80]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[81]  Lisa M Kaminskas,et al.  Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand. , 2018, Methods in molecular biology.